MedMira Inc (MIR) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.011x

Based on the latest financial reports, MedMira Inc (MIR) has a cash flow conversion efficiency ratio of 0.011x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-254.98K ≈ $-184.45K USD) by net assets (CA$-23.37 Million ≈ $-16.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

MedMira Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how MedMira Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MIR liabilities breakdown for a breakdown of total debt and financial obligations.

MedMira Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MedMira Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
K Wave Media Ltd.
NASDAQ:KWM
-22.973x
JSW Pacific
TWO:5251
-0.005x
TBH Global Co Ltd
KO:084870
0.031x
Halcyon Technology Public Company Limited
BK:HTECH
0.049x
Catcha Digital Bhd
KLSE:0173
0.064x
Cosol Ltd
AU:COS
0.059x
Unisync Corp
TO:UNI
0.296x
Coal Energy S.A.
WAR:CLE
0.080x

Annual Cash Flow Conversion Efficiency for MedMira Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of MedMira Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see MIR stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-07-31 CA$-22.56 Million
≈ $-16.32 Million
CA$-3.15 Million
≈ $-2.28 Million
0.139x -14.42%
2024-07-31 CA$-18.04 Million
≈ $-13.05 Million
CA$-2.94 Million
≈ $-2.13 Million
0.163x +93.17%
2023-07-31 CA$-15.03 Million
≈ $-10.87 Million
CA$-1.27 Million
≈ $-917.07K
0.084x -44.69%
2022-07-31 CA$-12.36 Million
≈ $-8.94 Million
CA$-1.88 Million
≈ $-1.36 Million
0.152x +375.09%
2021-07-31 CA$-15.72 Million
≈ $-11.37 Million
CA$-504.64K
≈ $-365.05K
0.032x +58.11%
2020-07-31 CA$-15.56 Million
≈ $-11.26 Million
CA$-315.90K
≈ $-228.51K
0.020x -70.85%
2019-07-31 CA$-13.52 Million
≈ $-9.78 Million
CA$-941.13K
≈ $-680.80K
0.070x -0.23%
2018-07-31 CA$-11.40 Million
≈ $-8.25 Million
CA$-795.41K
≈ $-575.38K
0.070x -66.83%
2017-07-31 CA$-8.98 Million
≈ $-6.50 Million
CA$-1.89 Million
≈ $-1.37 Million
0.210x -60.61%
2016-07-31 CA$-7.66 Million
≈ $-5.54 Million
CA$-4.09 Million
≈ $-2.96 Million
0.534x +75.38%
2015-07-31 CA$-7.70 Million
≈ $-5.57 Million
CA$-2.35 Million
≈ $-1.70 Million
0.305x -56.23%
2014-07-31 CA$-6.69 Million
≈ $-4.84 Million
CA$-4.66 Million
≈ $-3.37 Million
0.696x +685.62%
2011-07-31 CA$-19.11 Million
≈ $-13.83 Million
CA$-1.69 Million
≈ $-1.22 Million
0.089x -44.03%
2010-07-31 CA$-16.66 Million
≈ $-12.05 Million
CA$-2.64 Million
≈ $-1.91 Million
0.158x +25.16%
2009-07-31 CA$-16.00 Million
≈ $-11.57 Million
CA$-2.02 Million
≈ $-1.46 Million
0.126x -45.46%
2008-07-31 CA$-13.94 Million
≈ $-10.08 Million
CA$-3.23 Million
≈ $-2.34 Million
0.232x +40.86%
2007-07-31 CA$-12.78 Million
≈ $-9.24 Million
CA$-2.10 Million
≈ $-1.52 Million
0.165x -82.43%
2006-07-31 CA$-8.05 Million
≈ $-5.82 Million
CA$-7.54 Million
≈ $-5.45 Million
0.937x +70.96%
2005-07-31 CA$-9.80 Million
≈ $-7.09 Million
CA$-5.37 Million
≈ $-3.89 Million
0.548x +4.46%
2004-07-31 CA$-5.87 Million
≈ $-4.25 Million
CA$-3.08 Million
≈ $-2.23 Million
0.525x -61.59%
2003-07-31 CA$-2.19 Million
≈ $-1.58 Million
CA$-2.99 Million
≈ $-2.16 Million
1.366x +178.17%
2002-07-31 CA$-7.45 Million
≈ $-5.39 Million
CA$-3.66 Million
≈ $-2.64 Million
0.491x -51.47%
2001-07-31 CA$-6.01 Million
≈ $-4.35 Million
CA$-6.08 Million
≈ $-4.40 Million
1.012x +8.71%
2000-07-31 CA$-3.28 Million
≈ $-2.37 Million
CA$-3.05 Million
≈ $-2.21 Million
0.931x --

About MedMira Inc

V:MIR Canada Biotechnology
Market Cap
$30.27 Million
CA$41.85 Million CAD
Market Cap Rank
#23689 Global
#886 in Canada
Share Price
CA$0.06
Change (1 day)
+9.09%
52-Week Range
CA$0.06 - CA$0.10
All Time High
CA$0.70
About

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more